Literature DB >> 24807051

Multilaboratory assessment of threshold versus fold-change algorithms for minimizing analytical variability in multiplexed pneumococcal IgG measurements.

Thomas M Daly1, Jerry W Pickering2, Xiaochun Zhang3, Harry E Prince4, Harry R Hill5.   

Abstract

Pneumococcal vaccination is frequently used to assess a patient's humoral immune function. The comparison of pre- and postvaccination levels of antipneumococcal antibodies is widely held to be the gold standard for documenting a response. However, many of the published criteria for defining an adequate response are based on assays that are no longer widely available. We compared the clinical classification of patient response by multiplex pneumococcal assays currently performed at three large reference laboratories using a variety of published criteria for defining responses in adults. The classification of responders agreed for 79% of the patients when using a threshold-based algorithm compared to 57 to 96% of the patients when using various fold-change-based algorithms. The highest rate of discordance was seen when the most stringent criteria for response were used (4-fold increase postvaccination in 70% of serotypes). The discordant samples tended to show similar patterns of response across all three assays, with small variations in the final number of serotypes converting postvaccination. We conclude that the use of published cut points for documenting response to pneumococcal vaccination can be affected by interlaboratory differences in pneumococcal assays, particularly for algorithms that require large fold changes for a response to be documented. However, the overall patterns of response were similar in virtually all samples, regardless of the assay used.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24807051      PMCID: PMC4097436          DOI: 10.1128/CVI.00235-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  21 in total

Review 1.  Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Authors:  Catherine M Wernette; Carl E Frasch; Dace Madore; George Carlone; David Goldblatt; Brian Plikaytis; William Benjamin; Sally A Quataert; Steve Hildreth; Daniel J Sikkema; Helena Käyhty; Ingileif Jonsdottir; Moon H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 2.  Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

Authors:  Luis Jódar; Jay Butler; George Carlone; Ron Dagan; David Goldblatt; Helena Käyhty; Keith Klugman; Brian Plikaytis; George Siber; Robert Kohberger; Ih Chang; Thomas Cherian
Journal:  Vaccine       Date:  2003-07-04       Impact factor: 3.641

3.  Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens.

Authors:  Axel Jeurissen; Leen Moens; Marc Raes; Greet Wuyts; Luc Willebrords; Kate Sauer; Marijke Proesmans; Jan L Ceuppens; Kris De Boeck; Xavier Bossuyt
Journal:  Clin Chem       Date:  2007-01-26       Impact factor: 8.327

4.  A 22-plex chemiluminescent microarray for pneumococcal antibodies.

Authors:  Jerry W Pickering; Justin D Hoopes; Matthew C Groll; Heidi K Romero; Dave Wall; Howard Sant; Mark E Astill; Harry R Hill
Journal:  Am J Clin Pathol       Date:  2007-07       Impact factor: 2.493

5.  Validation of a multiplex pneumococcal serotyping assay with clinical samples.

Authors:  Jisheng Lin; Margit S Kaltoft; Angela P Brandao; Gabriela Echaniz-Aviles; M Cristina C Brandileone; Susan K Hollingshead; William H Benjamin; Moon H Nahm
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

6.  Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children.

Authors:  Wasu Kamchaisatian; Watcharaphong Wanwatsuntikul; John W Sleasman; Nutthapong Tangsinmankong
Journal:  J Allergy Clin Immunol       Date:  2006-11-07       Impact factor: 10.793

7.  A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides.

Authors:  Jerry W Pickering; Thomas B Martins; Ryan W Greer; M Carl Schroder; Mark E Astill; Christine M Litwin; Stephen W Hildreth; Harry R Hill
Journal:  Am J Clin Pathol       Date:  2002-04       Impact factor: 2.493

8.  Pneumococcal antibody levels in children with PID receiving immunoglobulin.

Authors:  David Tuerlinckx; Benoit Florkin; Alina Ferster; Iris De Schutter; Christophe Chantrain; Filomeen Haerynck; Pierre Philippet; Paul Strengers; Ruth Laub
Journal:  Pediatrics       Date:  2013-12-23       Impact factor: 7.124

9.  Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

Authors:  George R Siber; Ih Chang; Sherryl Baker; Philip Fernsten; Katherine L O'Brien; Mathuram Santosham; Keith P Klugman; Shabir A Madhi; Peter Paradiso; Robert Kohberger
Journal:  Vaccine       Date:  2007-02-21       Impact factor: 3.641

Review 10.  Assessment of the antibody response to pneumococcal vaccine in high-risk populations.

Authors:  S H Landesman; G Schiffman
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr
View more
  12 in total

1.  Improving vaccines against Streptococcus pneumoniae using synthetic glycans.

Authors:  Paulina Kaplonek; Naeem Khan; Katrin Reppe; Benjamin Schumann; Madhu Emmadi; Marilda P Lisboa; Fei-Fei Xu; Adam D J Calow; Sharavathi G Parameswarappa; Martin Witzenrath; Claney L Pereira; Peter H Seeberger
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

Review 2.  Use and clinical interpretation of pneumococcal antibody measurements in the evaluation of humoral immune function.

Authors:  Thomas M Daly; Harry R Hill
Journal:  Clin Vaccine Immunol       Date:  2014-12-17

Review 3.  Measuring immune responses to pneumococcal vaccines.

Authors:  David C LaFon; Moon H Nahm
Journal:  J Immunol Methods       Date:  2018-08-08       Impact factor: 2.303

4.  Interlaboratory variability in multiplexed pneumococcal antibody testing.

Authors:  David C LaFon; Moon H Nahm
Journal:  J Allergy Clin Immunol       Date:  2018-11-20       Impact factor: 10.793

5.  Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral Immunodeficiencies.

Authors:  Benjamin Lopez; Mathilde Bahuaud; Claire Fieschi; Souad Mehlal; Mohamed Jeljeli; Stéphanie Rogeau; Séverine Brabant; Anne-Sophie Deleplancque; Sylvain Dubucquoi; Sandrine Poizot; Louis Terriou; David Launay; Frédéric Batteux; Myriam Labalette; Guillaume Lefèvre
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

Review 6.  Specific Antibody Deficiency: Controversies in Diagnosis and Management.

Authors:  Elena Perez; Francisco A Bonilla; Jordan S Orange; Mark Ballow
Journal:  Front Immunol       Date:  2017-05-22       Impact factor: 7.561

7.  Multilaboratory Comparison of Pneumococcal Multiplex Immunoassays Used in Immunosurveillance of Streptococcus pneumoniae across Europe.

Authors:  Bob Meek; Nina Ekström; Bjørn Kantsø; Rachael Almond; Jamie Findlow; Jenna F Gritzfeld; Charlotte Sværke Jørgensen; Karl Ljungberg; Fredrik Atterfelt; Manou R Batstra; Kevin Andeweg; Ben A W de Jong; Harry E Prince; Mary Lapé-Nixon; Pieter G M Gageldonk; Irina Tcherniaeva; Ingeborg Aaberge; Tove Karin Herstad; Merit Melin; Ger T Rijkers; Guy A Berbers
Journal:  mSphere       Date:  2019-11-27       Impact factor: 4.389

8.  Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants.

Authors:  Elisa V Gomez; Jessie L Bishop; Kimberley Jackson; Talia M Muram; Diane Phillips
Journal:  BioDrugs       Date:  2017-12       Impact factor: 5.807

9.  Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients.

Authors:  Scott W Mueller; Laura J Baumgartner; Rob MacLaren; Robert Neumann; Arek J Wiktor; Tyree H Kiser; Gordon Lindberg; Luis Cava; Douglas N Fish; Edward N Janoff
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

10.  Focusing on Good Responders to Pneumococcal Polysaccharide Vaccination in General Hospital Patients Suspected for Immunodeficiency. A Decision Tree Based on the 23-Valent Pneumococcal IgG Assay.

Authors:  Lisanne M A Janssen; Michiel Heron; Jean-Luc Murk; Alexander C A P Leenders; Ger T Rijkers; Esther de Vries
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.